|1.||Rosenthal, Gary J: 4 articles (01/2014 - 05/2011)|
|2.||Hare, Joshua M: 3 articles (07/2015 - 04/2009)|
|3.||Richards, Jane P: 3 articles (01/2014 - 05/2011)|
|4.||Mutka, Sarah C: 3 articles (01/2014 - 05/2011)|
|5.||Qiu, Jian: 3 articles (01/2014 - 05/2011)|
|6.||Sun, Xicheng: 3 articles (01/2014 - 05/2011)|
|7.||Blonder, Joan P: 3 articles (01/2014 - 05/2011)|
|8.||Stamler, Jonathan S: 3 articles (04/2013 - 04/2009)|
|9.||Colagiovanni, Dorothy B: 3 articles (02/2012 - 05/2011)|
|10.||Balkan, Wayne: 2 articles (07/2015 - 04/2015)|
|1.||Asthma (Bronchial Asthma)
01/01/2015 - "An early-onset, allergic phenotype characterises the asthma population with increased S-nitrosoglutathione reductase activity. "
01/01/2015 - "Airway S-nitrosoglutathione reductase activity was increased in asthma patients (p=0.032). "
01/01/2015 - "We measured S-nitrosoglutathione reductase expression and activity in bronchoscopy samples taken from 66 subjects in the Severe Asthma Research Program. "
02/01/2012 - "A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma."
10/01/2011 - "The pyrrole based N6022 was recently identified as a potent, selective, reversible, and efficacious S-nitrosoglutathione reductase (GSNOR) inhibitor and is currently undergoing clinical development for the treatment of acute asthma. "
07/01/2015 - "S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial Infarction."
04/14/2009 - "Here we show that following left coronary artery ligation, mice with a targeted deletion of the S-nitrosoglutathione reductase gene (GSNOR(-/-)) have reduced myocardial infarct size, preserved ventricular systolic and diastolic function, and maintained tissue oxygenation. "
01/01/2014 - "Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation."
10/01/2015 - "Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis."
|1.||Glutathione (Reduced Glutathione)
|2.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|6.||Immunoglobulin E (IgE)
|9.||formic acid (formate)